Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity

Yueqiang Jiang, Yanling Ma, RuiChao Li, JianHai Sun

Open source

DOI
10.18632/oncotarget.22857
Published
2017-12-01
Container
Oncotarget
Publisher
Impact Journals, LLC
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.22857,
  title = {Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity},
  author = {Yueqiang Jiang and Yanling Ma and RuiChao Li and JianHai Sun},
  year = {2017},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.22857},
  url = {https://doi.org/10.18632/oncotarget.22857}
}

RIS

TY  - JOUR
TI  - Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity
AU  - Yueqiang Jiang
AU  - Yanling Ma
AU  - RuiChao Li
AU  - JianHai Sun
PY  - 2017
JO  - Oncotarget
DO  - 10.18632/oncotarget.22857
UR  - https://doi.org/10.18632/oncotarget.22857
ER  - 

APA

Jiang, Y., Ma, Y., Li, R., & Sun, J. (2017). Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity. Oncotarget. https://doi.org/10.18632/oncotarget.22857

Source records